Curcumin improves atherosclerosis by inhibiting the epigenetic repression of lncRNA MIAT to miR-124.

Ouyang, Shang; Zhang, Ou; Xiang, Hua; Yao, Yuan-Hui; Fang, Zhi-Yong

Ouyang, Shang; Zhang, Ou; Xiang, Hua; Yao, Yuan-Hui; Fang, Zhi-Yong.

Ouyang S; Department of Interventional Vascular Surgery, People's Hospital of Hunan Province, Changsha, China.
Zhang O; Department of Spinal Rehabilitation, Xiangya Boai Rehabilitation Hospital, Changsha, China.
Xiang H; Department of Interventional Vascular Surgery, People's Hospital of Hunan Province, Changsha, China.
Yao YH; Department of Interventional Vascular Surgery, People's Hospital of Hunan Province, Changsha, China.
Fang ZY; Department of Interventional Vascular Surgery, People's Hospital of Hunan Province, Changsha, China.

Vascular ; 30(6): 1213-1223, 2022 Dec.

Article en En | MEDLINE | ID: mdl-34989253

Asunto(s)

Aterosclerosis; Curcumina; MicroARNs; ARN Largo no Codificante; Humanos; Ratones; Animales; ARN Largo no Codificante/genética; ARN Largo no Codificante/metabolismo; ARN Largo no Codificante/farmacología; Curcumina/farmacología; Curcumina/metabolismo; Represión Epigenética; MicroARNs/genética; Aterosclerosis/tratamiento farmacológico; Aterosclerosis/genética; Aterosclerosis/prevención & control; Lipoproteínas LDL/farmacología; Apoptosis; Células Endoteliales de la Vena Umbilical Humana/metabolismo; Inflamación; Proliferación Celular

Palabras clave

Atherosclerosis; EZH2; MIAT; curcumin; miR-124

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Curcumina / MicroARNs / Aterosclerosis / ARN Largo no Codificante Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google